Wilson Sonsini Goodrich & Rosati advised Foresight on the deal.Foresight Diagnostics, Inc, a leading developer of ultrasensitive cancer detection tests, announced the close of an oversubscribed…
Foresight Diagnostics’ $58.75 Million Series B Financing Round
